Press releases
- Dexcom Reports First Quarter 2024 Financial Results
- Dexcom Publishes Annual Sustainability Report
- Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
- Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter
- Dexcom Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes With New Data at ATTD
- Dexcom Announces Upcoming Conference Presentation
More ▼
Key statistics
On Friday, Dexcom Inc (DC4:BRN) closed at 118.18, 0.00% below its 52-week high of 118.18, set on May 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 117.76 |
---|---|
High | 118.18 |
Low | 117.76 |
Bid | 115.73 |
Offer | 116.26 |
Previous close | 118.18 |
Average volume | 17.00 |
---|---|
Shares outstanding | 397.68m |
Free float | 396.24m |
P/E (TTM) | 83.03 |
Market cap | 50.10bn USD |
EPS (TTM) | 1.52 USD |
Data delayed at least 15 minutes, as of May 10 2024.
More ▼